Three hundred and eighty-one of the 458 DCIS cases could be classified into the surrogate molecular subtypes using 1% and 14% as cut offs for hormonal receptor status and proliferation, respectively. The gene discussed is NR4A1; the disease is ductal breast carcinoma in situ.